Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jan 24, 2022; 13(1): 62-70
Published online Jan 24, 2022. doi: 10.5306/wjco.v13.i1.62
Late recurrence of localized pure seminoma in prostate gland: A case report
Abinav Baweja, Nataliya Mar, Arash Rezazadeh Kalebasty
Abinav Baweja, Nataliya Mar, Arash Rezazadeh Kalebasty, Hematology/Oncology, UCI Medical Center, University of California, Orange, CA 92868, United States
Author contributions: All authors have made equal contributions, including literature search, article writing; all authors support for the publication of this manuscript.
Informed consent statement: Informed consent was obtained from the patient and documented for the purposes of the research.
Conflict-of-interest statement: There are no conflicts of interest to report from the authors of the manuscript.
CARE Checklist (2016) statement: All checklist items were completed to satisfy the requirements for publication.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Arash Rezazadeh Kalebasty, MD, Doctor, Hematology/Oncology, UCI Medical Center, University of California, Irvine Chao Family Comprehensive Cancer Center 101 The City Dr S, Orange, CA 92868, United States. arez@uci.edu
Received: April 2, 2021
Peer-review started: April 2, 2021
First decision: August 18, 2021
Revised: September 22, 2021
Accepted: December 28, 2021
Article in press: December 28, 2021
Published online: January 24, 2022
Core Tip

Core Tip: This case report describes of a patient with early-stage pure seminoma subsequently identified to have a recurrence within the prostate over two decades later. We provide a robust review of the literature focused on clinical factors, biology, and management of late recurrences specifically in pure seminoma and in prostate gland. There remains a lack of consensus data on treatment recommendations for this clinical disease. As such, a multidisciplinary approach emphasizing subspecialty expert consultation and patient education is imperative.